Braskem stock rating downgraded by UBS amid tough spread landscape

UBS downgraded Braskem from Buy to Neutral, reducing its price target to R$10.00 from R$15.00, citing a deteriorating short-term outlook and persistent industry challenges. The investment bank now projects a return to mid-cycle spreads no earlier than 2028 and notes that the company struggles to halt cash consumption without asset sales. UBS views higher import tariffs and specific programs as necessary conditions for Braskem's cash generation, rather than mere upside risks.

Analysis

UBS has downgraded Braskem from Buy to Neutral and significantly reduced its price target from R$15.00 to R$10.00, signaling a substantially more pessimistic short-term outlook. The downgrade is underpinned by a revised forecast that pushes the expected return to mid-cycle spreads out to 2028, highlighting persistent industry headwinds. A key concern is the company's ongoing cash consumption, which UBS notes is difficult to halt without measures such as asset sales. This negative outlook is compounded by a crucial shift in the analyst's perspective: previously considered upside catalysts, higher import tariffs and government support programs (REIQ/Presiq) are now viewed as necessary preconditions for Braskem to achieve positive cash generation. While UBS acknowledges Braskem's long-term potential due to its market leadership, the immediate financial challenges and dependency on external, non-guaranteed policy support dominate the current assessment.

Key Decisions for Investors

• Given the downgrade and the extended recovery timeline to 2028, investors should reassess their positions in Braskem, as the near-term risk profile has increased due to persistent cash consumption.
• Potential investors should exercise caution, as a return to cash generation is now viewed as dependent on uncertain external factors like higher import tariffs and specific government programs.
• Monitor the company's cash flow statements and any announcements regarding asset sales, as these are now critical indicators of its ability to stabilize operations and halt its cash burn.
• The significant 33% price target reduction to R$10.00 suggests that the market may re-price the stock lower to reflect the newly articulated near-term challenges.